Search results
Moderna (MRNA) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 11 months agoModerna's (MRNA) updated COVID-19 vaccine is designed to target the XBB.1.5 sublineage. The company...
Moderna says its updated COVID vaccine boosts protection against Omicron
LA Times via Yahoo News· 2 years agoModerna is among the COVID-19 vaccine makers studying updated boosters that can better protect...
Updated non-mrna COVID vaccine Novavax doses cost $130. What to know about coronavirus vax
Pensacola News Journal via Yahoo News· 7 months agoThe U.S. just approved the updated non-mRNA COVID-19 vaccine made by Novavax for use and millions of...
Moderna Just Took a Step Closer to Its Product Launch Goal. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 5 months agoModerna (NASDAQ: MRNA) today is known for its one and only product: the coronavirus vaccine now...
Another updated COVID vaccine could be available in the fall. Here’s what we know
Sacramento Bee via Yahoo News· 11 months agoCOVID-19 vaccines are due for another update and new formulas could be available in the U.S. by the...
US approves updated COVID vaccines to rev up protection this fall
Associated Press via AOL· 8 months agoThe U.S. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest...
FDA authorizes Novavax's updated COVID vaccine
CBS News via Yahoo News· 7 months agoThe Food and Drug Administration announced Tuesday it had authorized Novavax's updated COVID-19 vaccine, adding a third option for Americans ages 12 and...
Does This Message From Moderna Mean Bad News for Novavax?
Motley Fool· 8 months agoModerna (NASDAQ: MRNA) recently gave an update on its pipeline and future goals, and the biotech had...
CDC recommends updated Covid-19 vaccines for everyone 6 months and older
CNN via AOL· 8 months agoEveryone ages 6 months and older should get an updated Covid-19 vaccine, the US Centers for Disease...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 1 day agoNovavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their...
